K. Christopher Farkas - 16 Mar 2026 Form 4 Insider Report for CURTISS WRIGHT CORP (CW)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Mar 2026, 16:03:02 UTC
Prior SEC filing
10 Mar 2026
Next SEC filing
19 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
George P. McDonald by Power of Attorney from K. Christopher Farkas

Key filing fact

K. Christopher Farkas filed Form 4 for CURTISS WRIGHT CORP (CW) on 18 Mar 2026.

Key facts

  • This page summarizes K. Christopher Farkas's Form 4 filing for CURTISS WRIGHT CORP (CW).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Mar 2026, 16:03.

Change

  • Previous filing in this sequence was filed on 10 Mar 2026.
  • Current net transaction value: -$621,908.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001621241 Primary reporting owner

Farkas K Christopher

Relationship
Executive VP and CFO
Address
C/O CURTISS-WRIGHT CORPORATION, 130 HARBOUR PLACE DRIVE, DAVIDSON
Signature
George P. McDonald by Power of Attorney from K. Christopher Farkas
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CW transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,183
Change %
+51%
Price
$0.000000*
Shares after
6,436
Date
16 Mar 2026
Ownership
Direct
Footnotes
F1, F2
CW transaction

Common Stock

Sale

Transaction value
$621,908
Shares
-918
Change %
-14%
Price
$677.46
Shares after
5,518
Date
17 Mar 2026
Ownership
Direct
Footnotes
F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CW transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-2,183
Change %
-19%
Price
$0.000000*
Shares after
9,366
Date
16 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,183
Exercise price
$0.000000
Footnotes
F1, F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These shares were acquired through a restricted stock unit ("RSU") grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.

Footnote F2

No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.

Footnote F3

Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.

Footnote F4

The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.72 to $681.43, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Footnote F5

Share total includes dividend credits earned on prior outstanding grants.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .